CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,589,199 | +462.6% | 5,353,389 | +400.2% | 0.00% | – |
| Q2 2023 | $4,548,121 | -74.5% | 1,070,146 | -68.1% | 0.00% | -100.0% |
| Q1 2023 | $17,816,601 | -55.7% | 3,355,292 | -47.6% | 0.00% | 0.0% |
| Q4 2022 | $40,178,096 | +59.0% | 6,397,786 | +167.1% | 0.00% | -50.0% |
| Q3 2022 | $25,272,000 | +483.5% | 2,395,470 | +200.3% | 0.00% | – |
| Q2 2022 | $4,331,000 | -36.5% | 797,600 | +7.3% | 0.00% | – |
| Q1 2022 | $6,821,000 | +9.5% | 743,022 | +79.9% | 0.00% | – |
| Q4 2021 | $6,231,000 | -7.9% | 412,948 | +45.6% | 0.00% | – |
| Q3 2021 | $6,769,000 | – | 283,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 674,196 | $6,189,000 | 7.17% |
| 72 Investment Holdings, LLC | 474,067 | $4,352,000 | 4.76% |
| Velan Capital Investment Management LP | 210,695 | $1,934,000 | 1.80% |
| PFM Health Sciences, LP | 4,370,545 | $40,122,000 | 1.50% |
| Monashee Investment Management LLC | 470,000 | $4,315,000 | 1.25% |
| Avidity Partners Management LP | 2,819,067 | $25,879,000 | 0.54% |
| Rokos Capital Management LLP | 849,334 | $7,899,000 | 0.37% |
| Green Alpha Advisors, LLC | 49,674 | $456,000 | 0.31% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 181,304 | $1,664,000 | 0.25% |
| Tekla Capital Management LLC | 699,377 | $6,420,000 | 0.22% |